Skip to main content
Log in

Testicular neoplasms. Evaluation of the experience during 25 years in a military hospital

  • Research Articles
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Introduction

Testicular tumors are frequent in young adults, coinciding with incorporation to military service. The present study evaluates the tumor characteristics, time course and results obtained with the treatments used in our center for this type of neoplasms.

Material and methods

A retrospective longitudinal study was conducted in a cohort of 98 patients with an average age of 28.6 years, subjected to orchiectomy for testicular tumors in our center between 1979 and 2004. Data were collected relating to patient age, tumor characteristics, the outcome of treatment, and the course of the disease.

Results

The right testicle was affected in 61% (with significant differences versus the left side). The most common histological type corresponded to non-seminomatous germ cell tumors (NSGCTs) (65.3%), followed by pure seminomas (27.6%) and non-germinal cell tumors (NGCs) (7.1%). NSGCT was diagnosed at a significantly younger average age (23.2 years) than the other two tumor types. Stage I was the most frequent presentation (58%). Seminomas presented in stage I significantly more often (80%) than the others tumors. The data collected over the 25-year study period showed no significant variations in tumor characteristics. Thelog-rank test showed a significant difference in terms of patient survival according to the tumor cell line (p=0.000) and stage (p=0.000), except between stages I and II, where no significant differences were observed in terms of survival.

Conclusions

Non-seminomatous germ cell tumors (NSGCTs) are the most frequent testicular tumors in young adults. Most neoplasms are diagnosed in early stages, the prognosis being better in the case of seminomas and tumor stages I and II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schottenfield D, Warshauwe, ME, Sherlock S, Zauber AG, Leyder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980;112: 252–46.

    Google Scholar 

  2. Richie JP. Neoplasm of the testis. In: Campbell’s Urology 7th ed. Walsh PC et al, (edts) Philadelphia: Wb Saunder Co; 1997, p. 2411–52.

    Google Scholar 

  3. Yamane GK, Johnson R. Testicular carcinoma in US. Air Force aviators: a casecontrol study. Aviat Space Environ Med. 2003;74(8):846–50.

    PubMed  Google Scholar 

  4. Mostofi FK, Sobin LH. International histological clasification of tumor of the teste WHO: Geneve, 1977.

    Google Scholar 

  5. Mostofi FK, Sesterhenn IA. Histological typing of the testis tumors. WHO International Histological Clasification Tumors 2nd Edition Springer-Verlag: Berlin, 1998.

    Google Scholar 

  6. Medical Research Council Working Party on Testiculars Tumours. Prognostic factors in advanced non-seminomatous germcell testicular tumours: results of multicentre study. Lancet. 1985;1:8–11.

    Google Scholar 

  7. Germa-Lluch JR, García del Muro X, Maroto P, et al; Spanish Germ-Cell Cancer Group (GG). Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42(6): 553–63.

    Article  PubMed  CAS  Google Scholar 

  8. Tomomasa H, Shimizu H, et al. Clinical study of testicular germ cell tumors. Hinyokika Kiyo. 2001;47(6):389–95.

    PubMed  CAS  Google Scholar 

  9. Stone JM, Cruickshank DG, Sandeman TF, Matthews JP. Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer, in Victoria, Australia. Br J Cancer. 1991;64(1):152–8.

    Google Scholar 

  10. Soto Delgado M, Varo C, Juárez A, et al. Consideraciones sobre tumores de testiculo: nuestra experiencia. Arch Esp Urol. 1999;52(2):123–32.

    Google Scholar 

  11. Fernández Gómez JM, Guate Ortiz JL, Martin Huescar A, et al. Presentación clíníca del cancer germinal de testículo. Arch Esp Urol. 2002;55(8):915–22.

    Google Scholar 

  12. Gudbjartsson T, Magnusson K, Bergthorsson, J, et al. A population-based analysis of increased incidence and improved survival of testicular cancer patients in Iceland. Scand J Urol Nephrol. 2003;37 (4):292–8.

    Article  PubMed  Google Scholar 

  13. Abratt RP., Reddi VB, Sarembock LA. Testicular cancer and cryptorchidism. Br. J Urol. 1992;70(6):656–9.

    Article  PubMed  CAS  Google Scholar 

  14. Angwafo FF 3rd, Takongmo S, Mbakop A, Ngu VA. Testes tumors in a Sub-Saharan African city (Yaounde) Incident cases and histopathology. Eur. Urol. 1996;30(3): 345–8.

    PubMed  Google Scholar 

  15. Bridges PJ, Sharifi R, Razzaq A, Guinan P. Decreased survival of black Americans with testicular cancer. J Urol. 1998;159 (4):1221–3.

    Article  PubMed  CAS  Google Scholar 

  16. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170(1): 5–11.

    Article  PubMed  Google Scholar 

  17. Armora Mani J, Riera Canals L, Franco Miranda E, et al. Tumores germinales de testículo, casuística y revisión, bibliográfica. Actas Urol Esp. 1990;14(5):319–24.

    Google Scholar 

  18. Hernes EH, Harstad K, Fossa. Changing incidence and delay of testicular cancer in southern Norway (1981–1992). Eur Urol. 1996;30(3):349–57.

    PubMed  CAS  Google Scholar 

  19. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in testicular cancer incidence In. Vaud, Switzerland. Eur J Cancer Prev. 2003;12(4):347–9.

    Article  PubMed  CAS  Google Scholar 

  20. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003; 97(1):65–70.

    Article  Google Scholar 

  21. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Albers P, Habbema JD. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol. 2003;21(22):4092–9.

    Article  PubMed  Google Scholar 

  22. Erbay ME, Tarhan F, Barisik NO, Kuyumcuoglu U. A case of testicular rhabdomyosarcoma. Int Urol Nephrol. 2004;36 (1):73–5.

    Article  PubMed  Google Scholar 

  23. Cruceyra Betriu G, Tejido Sánchez A, Duarte Ojeda JM, et al.. Tumor de Leydig: presentación de 8 casos y revisión de la literatura. Acta Urol Esp. 2002;26(1):36–40.

    Google Scholar 

  24. Post PN Casparie MK, ten Kate FJ, Oosterhuis JW. The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA). Ned Tijdschr Geneeskd. 2004;148(23):1150–4.

    PubMed  CAS  Google Scholar 

  25. Santoni R, Barbera F, Bertoni F, et al. Stage I seminoma of the testis: a bi-institutional retrospective analysis ofpatients treated with radiation therapy only. BJU Int. 2003;92(1):47–52.

    Article  PubMed  CAS  Google Scholar 

  26. Warde P Gospodarowicz MK, Banerjee D, et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol. 1997;157(5):1705–9.

    Article  PubMed  CAS  Google Scholar 

  27. Laguna MP, Klepp O, Horwich A, et al. Guidelines on testicular cancer. European Association of Urology, 2004

  28. Krege S, Kalund G, Otto T, Goepel M, Rubben H. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Eur Urol. 1997;51(4): 405–7.

    Google Scholar 

  29. Bohlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol. 1999;161(4): 1148–52.

    Article  PubMed  CAS  Google Scholar 

  30. Classen J, Schmidberger H, Meisner C, et al. Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol. 2005;21(6):1101–6.

    Article  Google Scholar 

  31. Opot EN, Magoha GA. Testicular cancer at Kenyatta National Hospital. Nairobi. East Afr Med J. 2000;77(2):80–5.

    CAS  Google Scholar 

  32. Kim I, Young RH, Scully RE. Leydig cell tumor of the testis. A cliniccopathological analysis of 40 cases and review of the literature. Am J Sug Pathol. 1985:9(3):177–92.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miguel Vírseda-Chamorro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diz-Rodríguez, R., Vírseda-Chamorro, M., Paños-Lozano, P. et al. Testicular neoplasms. Evaluation of the experience during 25 years in a military hospital. Clin Transl Oncol 8, 681–687 (2006). https://doi.org/10.1007/s12094-006-0039-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-006-0039-3

Key words

Navigation